The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Cervical screening strategies: a modern perspective
Journal: Russian Bulletin of Obstetrician-Gynecologist. 2023;23(4): 20‑26
Views: 1524
Downloaded: 81
To cite this article:
Klinyshkova TV. Cervical screening strategies: a modern perspective. Russian Bulletin of Obstetrician-Gynecologist.
2023;23(4):20‑26. (In Russ.)
https://doi.org/10.17116/rosakush20232304120
According to World Health Organization cervical cancer is the fourth most common malignant disease among women in the world, the number of new cases in 2020 has reached 604 000. The Global Strategy to accelerate cervical cancer elimination as a public health problem, adopted in 2020, cervical screening is of paramount importance. Modern cervical screening involves a transition to primary screening for human papillomavirus (HPV screening) or co-testing (HPV test + cytology), followed by triage for high-risk HPV (HPV). A review and analysis of current data of domestic and foreign researches on this problem over the past 10 years are presented. Data on the efficacy of isolated cytological screening from the point of view of the cytological and histological correlation are presented. Evidence for informative HPV screening, triage-strategies of HPV-positive women, and the HPV screening interval are discussed. The role of the HPV test both as part of cervical screening and after treatment as a predictor of cervical intraepithelial neoplasia (CIN) recurrence is shown. The immunocytochemical method of double staining for proteins p16/Ki67 is suggested to determine the tactics for further management of HPV-positive women as a more informative one than the cytological method to detect CIN2+/CIN3+, the stratification of precancer risk was estimated if this method is used. The need for further studies to improve cervical screening strategies and to cooperate with the public health system to reduce morbidity and mortality associated with skin cancer is apparent.
Authors:
Received:
18.07.2022
Accepted:
09.08.2022
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.